Academic literature on the topic 'Murids'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Murids.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Murids"
Younas, Sana. "Piri-Muridi and Belief System: Role of Socio-Demographic Factors Within Pakistani context." Foundation University Journal of Psychology 4, no. 1 (April 8, 2020): 1–33. http://dx.doi.org/10.33897/fujp.v4i1.71.
Full textOld, J. M., and M. D. Price. "A case of melanoma in a native Australian murid, the spinifex hopping-mouse (Notomys alexis)." Australian Mammalogy 38, no. 1 (2016): 117. http://dx.doi.org/10.1071/am15010.
Full textBABOU, CHEIKH ANTA. "CONTESTING SPACE, SHAPING PLACES: MAKING ROOM FOR THE MURIDIYYA IN COLONIAL SENEGAL, 1912–45." Journal of African History 46, no. 3 (November 2005): 405–26. http://dx.doi.org/10.1017/s0021853705001295.
Full textASAKAWA, Mitsuhiko. "Parasitic nematodes of Japanese murids." Nematological Research (Japanese Journal of Nematology) 27, no. 1 (1997): 30–37. http://dx.doi.org/10.3725/jjn1993.27.1_30.
Full textROBINSON, DAVID. "THE MURIDS: SURVEILLANCE AND COLLABORATION." Journal of African History 40, no. 2 (July 1999): 193–213. http://dx.doi.org/10.1017/s0021853799007446.
Full textGaffney, Daniel, and Peter Keightley. "Genomic Selective Constraints in Murids." PLoS Genetics preprint, no. 2006 (2005): e204. http://dx.doi.org/10.1371/journal.pgen.0020204.eor.
Full textDEWI, KARTIKA, and ENDANG PURWANINGSIH. "A checklist of nematode parasites from Indonesian murids." Zootaxa 3608, no. 7 (January 24, 2013): 531–46. http://dx.doi.org/10.11646/zootaxa.3608.7.1.
Full textRoss, Eric. "Globalising Touba." Urban Studies 48, no. 14 (February 9, 2011): 2929–52. http://dx.doi.org/10.1177/0042098010391300.
Full textMcLennan, Hanna J., Stefan Lüpold, Pete Smissen, Kevin C. Rowe, and William G. Breed. "Greater sperm complexity in the Australasian old endemic rodents (Tribe: Hydromyini) is associated with increased levels of inter-male sperm competition." Reproduction, Fertility and Development 29, no. 5 (2017): 921. http://dx.doi.org/10.1071/rd15425.
Full textStjernholm, Simon. "The Centre of the Universe: Shaykh Nazim and His Murids in Lefke, Cyprus." Journal of Muslims in Europe 4, no. 1 (May 4, 2015): 38–57. http://dx.doi.org/10.1163/22117954-12341294.
Full textDissertations / Theses on the topic "Murids"
Friberg, Ida Mari. "Macroparasites, immune responses and immunoregulation in wild and laboratory murids." Thesis, University of Nottingham, 2012. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.575384.
Full textTyler, Angelia R. "Immigrant Experiences in the United States: The Murids of Senegal in New York." Scholarship @ Claremont, 2011. http://scholarship.claremont.edu/cmc_theses/249.
Full textSidlar, Katherine. "The role of sciurids and murids in the dispersal of truffle-forming ectomycorrhizal fungi in the Interior Cedar-Hemlock biogeoclimatic zone." Thesis, University of British Columbia, 2012. http://hdl.handle.net/2429/40418.
Full textde, la Fuente Hernández Noa. "Generación de modelos murinos de adenocarcinoma pancreático con mayor eficiencia metastásica para el estudio de agentes antitumorales." Doctoral thesis, Universitat Autònoma de Barcelona, 2021. http://hdl.handle.net/10803/673338.
Full textEl adenocarcinoma ductal de páncreas (ACDP) es un tumor agresivo, de biología tumoral y genética compleja. Presenta un mal pronóstico por su diagnóstico tardío y quimiorresistencia. El receptor de quimiocinas, CXCR4 es un marcador de células madre tumorales metastásicas. Varios estudios lo han asociado con un aumento de la invasión, la diseminación tumoral y la quimiorresistencia en tumores pancreáticos. Este receptor sería, por tanto, una diana excelente para el direccionamiento de una terapia antitumoral y antimetastásica. La motivación para la realización de este proyecto de tesis ha sido la necesidad de desarrollar trabajos de investigación que permitan encontrar nuevas herramientas para mejorar el diagnóstico, el pronóstico y el tratamiento del ACDP. En este trabajo se han generado modelos en ratón con una mayor eficiencia metastásica que permiten ampliar el estudio de esta patología. Estos modelos se han utilizado, además, para validar dos tratamientos del ámbito de la nanomedicina: una membrana constituída por nanofibras que permite una liberación local y controlada de fármaco en el tumor primario tras la resección quirúrgica, y una nanopartícula para la entrega dirigida de un citotóxico hacia las células madre tumorales CXCR4+, implicadas en el proceso de metástasis, permitiendo, en ambas estrategias, un aumento de la concentración farmacológica del compuesto antitumoral, y disminuyendo la toxicidad sistémica asociada al tratamiento. Los objetivos específicos de este proyecto han sido: la obtención de muestras de ACDP humano y el estudio de la expresión de CXCR4; la creación de modelos en ratón de ACDP de alta eficiencia metastásica a partir de líneas celulares de ACDP y muestras tumorales humanas con alta expresión de CXCR4; la evaluación, en xenógrafos ortotópicos pancreáticos, de la eficacia terapéutica de una membrana de nanofibras producida por la polimerización de ácido poli (láctico-co-glicólico, PLGA) y cargada en su matriz con el citotóxico SN-38 (CEB-01-SN38) en tratamiento único o en combinación con quimioterapia,y finalmente, el estudio de la citotoxicidad y biodistribución in vivo de la nanopartícula T22-O-Gemcitabina (T22-O-GEM), dirigida a la eliminación selectiva de las células madre metastásicas. Para ello, la metodología ha incluido experimentos in vitro (cultivo celular y la obtención de líneas tumorales PANC-1 y MIA PaCa-2 con expresión de CXCR4 y la obtención de una línea tumoral a partir de un tumor de ACDP de paciente), y experimentos in vivo: la generación de modelos subcutáneos de ADCP y modelos ortotópicos metastásicos, la implantación de membranas CEB-01, la administración de quimioterapia, el seguimiento del crecimiento tumoral y evaluación de las metástasis por bioluminiscencia), y finalmente, la evaluación de la citotoxicidad y biodistribución in vivo de T22-GFP-Gemcitabina y el análisis de la expresión de CXCR4 en muestras de pacientes con ACDP. Nuestras conclusiones son que la implantación de células tumorales con sobreexpresión de CXCR4 aumenta significativamente la diseminación tumoral y es útil para la evaluación preclínica de compuestos antitumorales, que la implantación ortotópica de biopsias humanas con alta expresión de CXCR4 es un modelo más predictivo para la clínica, que la implantación de la membrana CEB-01 cargada con el fármaco SN-38 permite el control del crecimiento tumoral local y su combinación con quimioterapia puede controlar la progresión tumoral y disminuir la carga tumoral metastásica, y que la nanopartícula T22-O-GEM presenta direccionamiento hacia células madre tumorales metastásicas e induce muerte celular. Este tratamiento podría conseguir un mayor efecto antitumoral comparado con el tratamiento estándar con Gemcitabina, disminuyendo, además, la toxicidad dependiente de dosis observada en los quimioterápicos utilizados habitualmente, no sólo en ACDP sino en otras neoplasias.
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive neoplasia with a complex tumor behaviour and genetics. It has a poor prognosis due to its late diagnosis and chemo- resistance. CXCR4, a marker of metastatic tumor stem cells, has been associated with an increase in invasion, tumor spread and chemoresistance in pancreatic tumors. This receptor could be a good target for the addressing of an anti-tumor and antimetastatic therapy. The motivation to perform this thesis has been the need to develop research work that will allow to find new tools that improve the diagnosis, prognosis and treatment of PDAC. In this work, mouse models have been generated with greater metastatic efficiency to expand the study of this pathology. They have also been used to validate two treatments in the field of nanomedicine, which allow a local controlled release of the drug in the primary tumor after surgical resection, and targeted administration of cytotoxic to CXCR4+ tumor stem cells, associated with metastasis, allowing an increase in pharmacological concentration and decreasing systemic toxicity. The specific objectives of this project have been to obtain samples from human PDAC and to study the expression of CXCR4, the development of high-efficiency metastatic mouse models of PDAC from PDAC cell lines and human tumor samples CXCR4+. Those models were used to evaluate the therapeutic efficacy of a nanofiber membrane produced by poly acid polymerization (lactic-co-glycolic) loaded with cytotoxic SN-38 (CEB-01-SN38) and treated alone or in combination with chemotherapy, and the study of in vivo cytotoxicity and biodistribution of the nanoparticle T22-O-Gemcitabine (T22-O-GEM), aimed at selective elimination of metastatic stem cells. To this end, the methodology has included conducting in vitro experiments: cell culture and obtaining PANC-1 and MIA PaCa-2 tumor lines with high CXCR4 expression and a tumor line from a patient's PDAC tumor, as well as in vivo experiments developing subcutaneous PDAC models and metastatic orthotopic models, implantation of CEB-01 membranes, administration of chemotherapy, monitoring of tumor growth and determination of metastases by bioluminescence, and finally, the evaluation of cytotoxicity and in vivo biodistribution of T22-GFP—GEM. Our conclusions are that implantation of tumor cells with CXCR4 overexpression significantly increases tumor spread being usefulness for preclinical evaluation of antitumor compounds. The orthotopic implantation of human biopsies with high expression of CXCR4 is a more predictive and translational model for preclinical assays. The implantation of the CEB-01 membrane loaded with the drug SN-38, can control the local tumor growth alone or combined with chemotherapy, decreasing metastatic tumor spread, and finally, the T22-O-GEM nanoparticle could be used to eliminate metastatic cancer stem cells and it might induce greater antitumor effects than the standard treatment with Gemcitabine, reducing the side effects of standard chemotheratic treatments.
Universitat Autònoma de Barcelona. Programa de Doctorat en Cirurgia i Ciències Morfològiques
Shears, Rebecca. "Defining the host protective antigens secreted by the murine whipworm, Trichuris muris." Thesis, University of Manchester, 2017. https://www.research.manchester.ac.uk/portal/en/theses/defining-the-host-protective-antigens-secreted-by-the-murine-whipworm-trichuris-muris(34417c03-44c9-46ff-bae8-9509f4c74e1c).html.
Full textBastos, Rosidete Pereira. "Infecção murina por isolados de Leishmania (Viannia) braziliensis: avaliação da participação de leucotrienos endógenos." Universidade Federal de Goiás, 2008. http://repositorio.bc.ufg.br/tede/handle/tede/4187.
Full textApproved for entry into archive by Luciana Ferreira (lucgeral@gmail.com) on 2015-02-20T11:34:34Z (GMT) No. of bitstreams: 2 Dissertação - Rosidete Pereira de Bastos - 2008.pdf: 938423 bytes, checksum: 1e65715cda59aae81ec161a84d517cb6 (MD5) license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5)
Made available in DSpace on 2015-02-20T11:34:34Z (GMT). No. of bitstreams: 2 Dissertação - Rosidete Pereira de Bastos - 2008.pdf: 938423 bytes, checksum: 1e65715cda59aae81ec161a84d517cb6 (MD5) license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5) Previous issue date: 2008-03-14
Conselho Nacional de Pesquisa e Desenvolvimento Científico e Tecnológico - CNPq
The knowledge about immunology of Leishmania (Viannia) braziliensis-murine infection is poorly known, especially concerning innate immune response and the involvement of leukotrienes in the resistance mechanisms. Leukotrienes are lipid mediators of inflammation that activate microbicidal mechanisms in leukocytes. The present study aimed to evaluate the BALB/c and C57Bl/6 murine infection with two L. (V.) braziliensis isolates obtained from cutaneous leishmaniasis patients and the involvement of leukotrienes in the resistance of infection. Thus, IMG3 and RPL5 isolates were identified as L. (V.) braziliensis by using molecular techniques and the in vitro growth of parasites in Grace´s medium (26°C) was evaluated. The time course of lesion after footpad infection was followed in BALB/c and C57Bl/6 mice. C57Bl/6 mice genetically deficient in interferon gamma (IFNγ) were infected to evaluate the relevance of this cytokine in resistance. The parasite burden in draining lymph nodes and spleens was detected by limiting dilution assay. BALB/c- and C57Bl/6-infected footpads were processed after 12 weeks of infection and those from IFNγ-defecient mice after 4 weeks for histopathological analyses. Tissue sections were stained by hematoxylin-eosin. Parasite capacity to induce nitric oxide (NO) was analyzed in RAW 264.7 cell cultures treated or not with IFNγ and lipopolysaccharide (LPS). Nitrites were detected by using Griess reaction. The NO modulation by endogenous leukotrienes was evaluated through treatment of the cultures with a 5-lipoxygenase (5-LO) inhibitor and a leukotriene B4 (LTB4) antagonist. Macrophage leishmanicidal activity against IMG3 isolate was evaluated in thioglycolateelicited peritoneal macrophages of C57Bl/6 mice. In these cultures, NO was inhibited by aminoguanidine. In vivo leukotriene inhibition was achieved by using a 5-LO inhibitor. In vitro-parasite growth profiles were similar and parasites at the 5th day of culture were used to infection. The lesion course was also similar between isolates in both two mouse stains used, but C57Bl/6 mice presented healing after 12 weeks of infection whereas in BALB/c mice the lesion was persistent. In IFNγ-deficient mice there progressive lesions and visceralization in IMG3- as well as in RPL5-infected mice. Corroborating these data, the parasite burden in draining lymph nodes of BALB/c mice was higher than in C57Bl/6 mice after 12 weeks of infection with IMG3, and parasites (IMG3 and RPL5) were identified in about 50% of the IFNγ-deficient mouse spleens. The histopathological analyses showed an intense dermal infiltrate with vacuolated macrophages heavily parasitized in BALB/c mice (12 weeks) an in IFNγ-deficient mice (4 weeks), but not in C57Bl/6 mice (12 weeks), similarly for IMG3 and RPL5. Both isolates IMG3 an RPL5 induced NO production in RAW 264.7 celll cultures presenting synergism with IFNγ. Endogenous leukotrienes did not affect NO production in these cultures. C57Bl/6 peritoneal macrophages activated with IFNγ/LPS killed IMG3 parasites depending on NO release. In vivo inhibition of leukotriene synthesis did not change the course of infection in C57Bl/6 mice infected with IMG3 isolate. The relevant findings are: BALB/c mouse is susceptible to infection with IMG3 an RPL5 isolates whereas C57Bl/6 is resistant; IFNγ is crucial to the control of the infection; the isolates induce NO and this molecule contributes to macrophage leishmanicidal activity; and also the data suggest that endogenous leukotrienes are not involved in the control of L. (V.) braziliensis in C576Bl/6 mouse.
A imunologia da infecção murina por Leishmaia (Viannia) braziliensis é pouco conhecida, especialmente considerando a imunidade inata e a participação dos leucotrienos nos mecanismos de resistência à infecção. Os leucotrienos são mediadores lipídicos da inflamação que ativam mecanismos microbicidas dos leucócitos. O presente trabalho teve como objetivo avaliar o perfil da infecção de camundongos BALB/c e C57Bl/6 por dois isolados de L. (V.) braziliensis obtidos de pacientes com leishmaniose cutânea e o envolvimento dos leucotrienos endógenos na resistência à infecção. Para isto, os isolados denominados IMG3 e RPL5 foram identificados como L. (V.) braziliensis por meio de técnicas moleculares e foram avaliados quanto ao crescimento in vitro em meio Grace (26°C), e quanto ao curso da evolução da lesão, em camundongos BALB/c e em C57Bl/6. Camundongos C57Bl/6 geneticamente deficientes em interferon gama (IFNγ) foram infectados para avaliar a importância desta citocina no controle da infecção. A carga parasitária foi obtida pelo ensaio da diluição limitante em linfonodos drenantes da lesão e nos baços. As patas dos camundongos BALB/c e C57Bl/6 foram colhidas após 12 semanas de infecção, e dos camundongos deficientes em IFNγ, na 4ª semana, e foram processadas para análises hitopatológicas. A capacidade de indução de óxido nítrico (NO) pelos isolados foi avaliada em culturas de células RAW 264.7 tratadas ou não com IFNγ e lipopolissacarídeo (LPS), sendo os nitritos detectados por reação de Griess. A regulação da produção de NO pelos leucotrienos endógenos foi avaliada por tratamento das culturas de macrófagos com um inibidor de 5-lipoxigenase (5-LO) e um antagonista de receptor de leucotrieno B4 (LTB4). A atividade microbicida dos macrófagos foi avaliada em macrófagos peritoneais (C57Bl/6) infectados com o isolado IMG3, sendo o NO inibido por aminoguanidina. O efeito da inibição de leucotrienos, in vivo, foi avaliado em camundongos C57Bl/6 infectados com o isolado IMG3 e tratados com um inibidor de 5- LO. As curvas de crescimento in vitro foram similares para os dois isolados e os parasitos no 5° dia de cultivo foram usados nos experimentos de infecção. O curso da lesão foi similar entre os dois isolados nos camundongos BALB/c e C57Bl/6, porém enquanto a lesão regrediu nos C57Bl/6, nos camundongos BALB/c, a lesão foi persistente até a 12ª semana de infecção. Em camundongos deficientes em IFNγ houve crescimento progressivo das lesões e visceralização, tanto com o isolado IMG3 quanto com o RPL5. Confirmando estes dados, a carga parasitária nos linfonodos drenantes da lesão nos camundongos BALB/c foi maior do que a encontrada nos C57Bl/6 após 12 semanas de infecção com IMG3 e os parasitos (IMG3 e RPL5) foram encontrados em cerca de 50% dos baços dos camundongos deficientes em IFNγ. As análises histopatológicas mostraram um acentuado infiltrado inflamatório na derme, com macrófagos vacuolizados repletos de parasitos nos camundongos BALB/c (12 semanas), e nos deficientes de IFNγ (4 semanas), mas não nos camundongos C57Bl/6 (12 semanas), similarmente para IMG3 e RPL5. Os isolados IMG3 e RPL5 induziram NO em células RAW 264.7 em sinergismo com IFNγ e os leucotrienos endógenos não alteraram a produção de NO destas células. Macrófagos peritoneais murinos mostraram atividade microbicida de maneira dependente de NO. A inibição in vivo da síntese de leucotrienos não alterou o curso da infecção pelo isolado IMG3 em camundongos C57Bl/6. Coletivamente, os dados mostram que o camundongo BALB/c é suscetível à infecção pelos dois isolados, enquanto o C57Bl/6 é resistente; o IFNγ é essencial para o controle da infecção; os isolados induzem a produção de NO, o qual contribui para a eliminação dos parasitos; e os dados sugerem que os leucotrienos endógenos não estão envolvidos nos mecanismos de resistência dos camundongos C57Bl/6 a L. (V.) braziliensis.
Rodrigues, Raquel Ferreira. "Estudo dos compostos mesoiônicos tiadiazólicos contra Leishmania sp e inibição da tripanotiona redutase." reponame:Repositório Institucional da FIOCRUZ, 2011. https://www.arca.fiocruz.br/handle/icict/4275.
Full textMade available in DSpace on 2012-08-13T04:37:36Z (GMT). No. of bitstreams: 1 raquel_f_rodrigues_ioc_bp_0056_2011.pdf: 571332 bytes, checksum: b292e41b82ba36c32976100adb623288 (MD5) Previous issue date: 2011
Fundação Oswaldo Cruz. Instituto de Comunicação e Informação Cientifica e Tecnológica em Saúde. Rio de Janeiro, RJ, Brasil.
A leishmaniose é uma das principais doenças parasitárias com prioridades de pesquisa segundo a Organização Mundial da Saúde. Aurgência por drogas mais seletivas e menos tóxicas tenm conduzido a pesquisa por novas terapias químicas. Os compostos mesoiônicos (Mls) da classe 1,3,2 - tiadiazol-2-aminida, apresentam um amplo espectro de atividades biológica, incluindo efeitos antitumoral e leishmanicida. Neste estudo investigamos a atividade in vitro de Ml-HH, Ml-4-NO2, Ml-3OCH3 e Ml-4-OCH3 sobre promastigotas e amastigotas axênicas de L. infantum e amastigotas intracelulares de L. infantum e L. amazonensis. Uma alta atividade leishmanicida foi demonstrada contra L. infantum e constatou-se uma relação de dose-resposta para formas amastigotas intracelulares de L. infantum e L. amazonensis pelo Ml-4-NO2. Em etapa seguinte investigamos in vivo o efeito de Mls nos seguintes modelos camundongo/parasito: CBA/J e L. amazonensis, BALB/c e L. amazonensis e BALB/c e L. infantum. No primeiro modelo, a administração por via subcutânea de Ml-HH e Ml-4-OCH3 levou a uma diminuição da carga parasitária no linfonodo adjacente à lesão e no baço. Nos dois modelos seguintes, altamente sensíveis à infecção, foram estudados Ml-HH, Ml-4-NO2, avaliando além de parâmetros daresposta terapêutica e tóxicos, possíveis efeitos imunomoduladores. Camundongos susceptíveis da linhagem BALB/c foram infectados por via subcutânea na pata com promastigotas de L. amazonensis e viaintraperitonal por L. infantum. Os tratamentos utilizados foram por vias tópica, intralesional para leishmaniose cutâna (LC) e intraperitoneal para leishmaniose visceral (LV). Glucantime, droga anti-Leishmania clássica, foi utilizada como referência. Embora a cura completa não tenha sido observada nos animais com LC, os grupos tratados com Ml-4 - NO2 e Ml-4-OCH3 apresentaram pequenas lesões na pata infectada até 12ª semana após a infecção sem apresentar ulcerações. Ogrupo LV tratado com Ml-4-NO2 apresentou carga parasitária negativa no baçço e no fígado. O tratamento de LV com Glucantime e Ml-4-OCH3 reduziu de forma significativa a carga parasitária. Porém o tratamento com Ml-HH, em todas as vias utilizadas, não apresentou atividade terapêutica para LC ou LV. A avaliação de enzimas hepáticas (AST e ALT) e de creatinina apontam para a ausência de toxidade no tratamento com Mls. Além disso, também foram realizados estudos na tentativa de buscar um alvo de ação destes compostos, investigando-se a tripanotiona redutase, enzima específica no parasito, responsável por desencadear uma cascata dedetoxificação nos parasitos. Estudos de cinética enzimática (enzimas recombinantes de L. infantum e T. cruzi) e modelagem molecular indicaram que Ml-4-NO2 é o único derivado mesoionico, dentre os estudados, capaz de inibir de forma não- competitiva esta enzima. Todos esses resultados demonstraram que Mls podem ser uma nova perspectiva no desenvolvimento de drogas com menor toxidade e capazes de modificar a resposta imunológica no combate a infecção por Leishmania, além de atuar sobre um alvo específico no parasito
Leishmaniasis is a parasitic disease with the main research priorities according to World Health Organization Aurgência drug more selective and less toxic tenm conducting research for new chemical therapies. The mesoionic compound (mls) of the class 1,3,2 - thiadiazol-2-aminida, have a broad spectrum of biological activities, including antitumor effects and antileishmanial. We investigated the in vitro activity of HH-Ml, Ml-4-NO2,-3OCH3 Ml and Ml-4-OCH3 on promastigotes and axenic amastigotes of L. infantum and intracellular amastigotes of L. infantum and L. amazonensis. A high leishmanicidal activity was demonstrated against L. infantum and it was observed a dose-response for intracellular amastigote L. infantum and L. amazonensis by ML-4-NO 2. In next step we investigate in vivo the effect of MLS in the following models mouse / parasite: CBA / J and L. amazonensis, BALB / c and L. amazonensis and BALB / c and L. infantum. In the first model, the subcutaneous administration of ML-HH and ML-4-OCH 3 led to a reduction of parasite load in lymph node adjacent to the lesion and the spleen. In both models the following, highly susceptible to infection have been studied HH-ML, ML-4-NO 2, besides evaluating parameters daresposta therapeutic and toxic potential immunomodulatory effects. Susceptible mice of BALB / c mice were infected subcutaneously in the foot with a promastigote L. by L. amazonensis and viaintraperitonal infantum. The treatments were used by inland topical, intralesional cutâna for leishmaniasis (CL) and intraperitoneal for visceral leishmaniasis (VL). Glucantime, anti-Leishmania classical drug was used as reference. While the complete healing was not observed in animals with LC, the groups treated with ML-4 - NO2 and ML-4-OCH 3 showed small lesions in the infected foot up to 12 weeks after infection without presenting ulcerations. GROUP Ml treated with LV-4-NO2 showed negative bacco parasite load and liver. Treatment of VL with Glucantime and Ml-4-OCH3 significantly reduced parasite burden. However, treatment with ML-HH in all pathways used, had no therapeutic activity for LV or LC. The evaluation of liver enzymes (ALT and AST) and creatinine indicate the absence of toxicity in the treatment mls. In addition, studies were performed in an attempt to seek a target of action of these compounds by investigating whether the trypanothione reductase, an enzyme specific to the parasite responsible for triggering a cascade dedetoxificação in parasites. Kinetic studies enzyme (enzymes of L. infantum and recombinant T. cruzi) and molecular modeling indicated that ML-4-one derivative is NO2 mesoionico, of those studied, capable of inhibiting a non-competitive this enzyme. All these results showed that MLs may be a new perspective in the development of drugs with lower toxicity and can modify the immune response to fight infection by Leishmania, and act on a specific target in the parasite
Charret, Karen dos Santos. "Efeitos dos componentes acilhidrazonas pirazólicas sobre as formas evolutivas da Leishmania amazonensis e na infecção experimental em camundongos isogênicos CBA." reponame:Repositório Institucional da FIOCRUZ, 2011. https://www.arca.fiocruz.br/handle/icict/5831.
Full textMade available in DSpace on 2012-11-19T18:30:11Z (GMT). No. of bitstreams: 1 karen_s_charret_ioc_bp_0055_2011.pdf: 28875915 bytes, checksum: 38bf86603dba71d83a48b9e25560c47f (MD5) Previous issue date: 2011
Fundação Oswaldo Cruz.Instituto Oswaldo Cruz. Rio de janeiro, RJ, Brasil
Atualmente, não há vacina eficaz e o controle das leishmanioses depende principalmente da quimioterapia. Recentemente, novos compostos sintéticos os derivados carbohidrazidas pirazolocas apresentaram atividade em Leishmania amazonensis in vitro e quando testadas em modelo experimental murino de infecção de L. amazonensis mostraram eum efeito um efeito terapêutico significativo. Um estudo com compostos intermediários da síntesedas carbohidrazidas poderia ser interessante, pois estes possuem uma potencial atividade leishmanicida e ajudaria a cmpreender os mecanismos de ação dos compostos finais. Por outro lado, é necessário conhcer o comportamento do sistema imune frente a estes compostos na infecção por leishmaniose.Os compostos precursores naão foram ativos em formas promastigotas de L. amazonensis. No entanto, todos os compostos apresentaram atividade sobre formas de amastigotas e sem citotoxicidade em célula de mamíferos. Aqui, foi sugerida a contribuição farmacofórica do anel N-heteroaromático para a atividade leishmanicida e do grupamento hidrazina para o composto intermediário. Além disso, foi mostrado que todos os componentes podem induzir um aumento da produção de óxido nitrico em macrófagos estimulados ou não. Em camundongos CBA infectados com L amazonensis e tratados por via oral com os derivados carbohidrazidas, o estudo histopatológico rervelou que mudanças na derme foram correlacionadas com o tamanho macroscópico da lesão. Camundongos CBA infectados e tratados tinham lesões cutâneas menores, e as estruturas da epiderme e derme tinham níveis mais baixos de infiltrtado inflamatório, comparadas com as de camundongos controles infectados e não tratados. Também foi observado um infiltrado inflamatório misto contendo linfócitos e neutrófilos. Além disso, expressão de IL-4 RNAm foi menor no grupo tratado.. Um aumento dos níveis de anticorpos das subclasses específicas anti-Leishmania IgG2a e IgG3 foi observado nos grupos tratados com as pirozol carbohidrazidas exercem efeitos terapêuticos significativos, podendo agir diretamente sobre o parasito e/ou sobre as células dos sistemas imune do hospedeiro..
Currently, there is no effective vaccine and control of leishmanioses depends mainly on the chemotherapy. Recently, new synthetic carbohidrazidas derivatives pirazolocas compounds showed activity on Leishmania amazonensis when tested in vitro and in experimental murine model of infection of l. amazonensis showed a significant therapeutic effect effect. A study of intermediate compounds síntesedas carbohidrazidas could be interesting, as these have a potential activity leishmanicida and help cmpreender the mechanisms of action of compounds. On the other hand, it is necessary to know the behavior of the immune system against these compounds in leishmaniasis infection.The precursor compounds are active in ways does promastigotas of l. amazonensis. However, all compounds showed activity on amastigote forms and without cytotoxicity in mammalian cell. Here, it was suggested the contribution farmacofórica of the ring N-heteroaromatic compound for leishmanicida and activity of hydrazine to the intermediate grouping. In addition, it was shown that all components can induce an increase in nitric oxide production in macrophages stimulated or not. In CBA mice infected with l. amazonensis and treated orally with carbohidrazidas derivatives, the histopathologic study rervelou that changes in the DermIS were correlated with the macroscopic size of the lesion. CBA mice infected and treated tin
Ducroz, Jean-François. "Contribution des approches cytogénétique et moléculaire a l'étude systématique et évolutive des genres de rongeurs de la division arvicanthis (rodentia, muridae)." Paris, Muséum national d'histoire naturelle, 1998. http://www.theses.fr/1998MNHN0030.
Full textPereira, Natalia Rubio Claret. "Eficácia terapêutica de nanocápsulas de metotrexato em glioblastoma murino: estudos in vivo e in vitro." Universidade de São Paulo, 2015. http://www.teses.usp.br/teses/disponiveis/9/9141/tde-02062015-134406/.
Full textGlioblastoma multiforme (GBM) is a serious disease and no effective treatment is availabe, especially because the drugs cause significant adverse reactions in therapeutic doses. Methotrexate (MTX) is a cytotoxic drug used to treat many neoplasms, however, their use is limited by the low bioavailability and adverse reactions. Nanotechnology has been used to increase the effectiveness of antitumor drugs in order to direct them to the site of action and to reduce adverse effects. Accordingly, we carried out an experimental approach with MTX lipid nanocapsules (MTX LNC) to evaluate the uptake mechanisms in glioblastoma and microglia cell lines, and the therapeutic efficacy of MTX LNC in vitro and in vivo systems. Initially, fluorescence microscopy assays employing specific pharmacological blockers for membrane transport showed that the MTX LNC stained with Rhodamine B penetrated into GL261 tumor cells by caveolae-mediated endocytosis, and in BV2 microglia cells by phagocytosis and macropinocytosis. Treatment with MTX solution or MTX LNC (at corresponding concentrations) on GL261 cells inhibited the proliferation; increased DNA fragmentation, but only the LNC induced cell death by necrosis and decreased the number of cells in the G1/G0 phase of the cell cycle. In BV2 cells, treatment with MTX solution or MTX LNC inhibited proliferation, reduced number of cells in the G1/G0 phase of the cell cycle, increased DNA fragmentation and cell death, induced by apoptosis and late apoptosis. Intravital microscopy study showed that the MTX LNC across the Blood-Brain Barrier (BBB) of C57BL/6 female mice after intravenous or oral administrations, without damaging its structure. The area of glioblastoma in vivo was reduced in animals oral treated with MTX LNC comparing to saline treated mice. This reduction was not observed in animals treated with MTX solution. Together, the data herein obtained show that MTX LNC penetrate the cell membrane and cause cell toxicity on glioma and neurons lineage, cross the BBB and suggest that the nanoencapsulation of MTX can be an important strategy for the treatment of glioblastoma.
Books on the topic "Murids"
Dahri, Harapandi. Keperibadian guru dan murid. Bandar Seri Begawan, Negara Brunei Darussalam: Pusat Penerbitan, Kolej Universiti Perguruan Ugama Seri Begawan, 2014.
Find full textLumsden, Katherine. Belfasts murals. Dublin: National College of Art and Design, 1998.
Find full textauthor, Suresh S., and Archæological Survey of India, eds. Kerala murals. New Delhi: The Director General, Archaeological Survey of India, 2015.
Find full textMurado, Antonio. Antonio Murado. Galicia (Spain : Region): Consellería de Cultura e Xuventude, 1990.
Find full textMuris, Johannes de. Johannis de Muris musica (speculativa). Ottawa, Canada: Institute of Mediaeval Music, 1994.
Find full textHadish, Yetty Kusmiyati. Pelajaran bahasa Sunda murid SLP. Jakarta: Pusat Pembinaan dan Pengembangan Bahasa, Departemen Pendidikan dan Kebudayaan, 1985.
Find full textBudianta, Eka. Cermin ilalang: Kenangan murid M.S. Kismadi. Jakarta?]: Memoar Indonesia, 2005.
Find full textBook chapters on the topic "Murids"
van Dam, Jan. "Stephanodonty in Fossil Murids." In Advances in Morphometrics, 449–61. Boston, MA: Springer US, 1996. http://dx.doi.org/10.1007/978-1-4757-9083-2_39.
Full textPage, Norman. "A Writer’s Life." In Muriel Spark, 1–9. London: Macmillan Education UK, 1990. http://dx.doi.org/10.1007/978-1-349-20716-9_1.
Full textPage, Norman. "Angels Dining at the Ritz: The Early Novels." In Muriel Spark, 10–53. London: Macmillan Education UK, 1990. http://dx.doi.org/10.1007/978-1-349-20716-9_2.
Full textPage, Norman. "Interlude." In Muriel Spark, 54–63. London: Macmillan Education UK, 1990. http://dx.doi.org/10.1007/978-1-349-20716-9_3.
Full textPage, Norman. "Foreign Parts: The Later Novels." In Muriel Spark, 64–110. London: Macmillan Education UK, 1990. http://dx.doi.org/10.1007/978-1-349-20716-9_4.
Full textPage, Norman. "Back to the Fifties." In Muriel Spark, 111–15. London: Macmillan Education UK, 1990. http://dx.doi.org/10.1007/978-1-349-20716-9_5.
Full textPage, Norman. "Postscript." In Muriel Spark, 116–22. London: Macmillan Education UK, 1990. http://dx.doi.org/10.1007/978-1-349-20716-9_6.
Full textGlover, John. "Murid Modernity." In New Perspectives on Islam in Senegal, 71–88. New York: Palgrave Macmillan US, 2009. http://dx.doi.org/10.1057/9780230618503_4.
Full textRousman, Corentin. "Mons, ville ouverte. Un nouveau projet urbanistique pour la cité." In Extra muros, 141–76. Köln: Böhlau Verlag, 2019. http://dx.doi.org/10.7788/9783412515164.141.
Full textDenys, Catherine. "Le contrôle policier des espaces suburbains à Bruxelles au XVIIIe siècle." In Extra muros, 333–50. Köln: Böhlau Verlag, 2019. http://dx.doi.org/10.7788/9783412515164.333.
Full textConference papers on the topic "Murids"
Quinet Pifano, Raquel. "Os Retratos Pictóricos de Murilo Mendes na Coleção do Poeta." In Colóquio do Comitê Brasileiro de História da Arte. Comitê Brasileiro de História da Arte, 2021. http://dx.doi.org/10.54575/cbha.40.06.
Full textSampaio, Marina Carvalho, Andreia Camargo Pinheiro, Vitória Regina Pereira Da Silva, Gisela De Jesus Felice, and Graziella Anselmo Joanitti. "EFEITOS DE NANOEMULSÃO À BASE DE ÓLEO DE COPAÍBA (COPAIFERA OFFICINALIS) EM CÉLULAS DE MACRÓFAGOS IN VITRO." In III Congresso Brasileiro de Ciências Farmacêuticas On-line. Revista Multidisciplinar em Saúde, 2022. http://dx.doi.org/10.51161/conbracif/07.
Full textMoffat, E. H., R. H. Furlong, A. L. Bloom, and J. C. Giddings. "A MURINE MODEL FOR FACTOR VIII ANTIBODY ANTI-IDIOTYPE REAGENTS." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644030.
Full text"Assessing last mile delivery strategies � A hybrid solution approach." In 24th International Congress on Modelling and Simulation. Modelling and Simulation Society of Australia and New Zealand, 2021. http://dx.doi.org/10.36334/modsim.2021.m1.muriel.
Full textChihai, Oleg, Dumitru Erhan, Stefan Rusu, Nina Talambuta, Victoria Nistreanu, Alina Larion, Maria Zamornea, and Galina Melnic. "Structura parazitismului la șoarecele scurmător in ecosisteme forestiere." In International symposium ”Functional ecology of animals” dedicated to the 70th anniversary from the birth of academician Ion Toderas. Institute of Zoology, Republic of Moldova, 2019. http://dx.doi.org/10.53937/9789975315975.35.
Full textGilliam, Andrew D., and Scott T. Acton. "Murine Spatiotemporal Cardiac Segmentation." In 2007 41st Asilomar conference on Signals, Systems and Computers (ACSSC). IEEE, 2007. http://dx.doi.org/10.1109/acssc.2007.4487313.
Full textPetrovic, Aleksandra, Ivana Ivanovic, Vojislava Bursic, Gorica Vukovic, Nikola Puvaca, Dušan Marinkovic, and Bojan Konstantinovic. "STRIPED FIELD MOUSE (APODEMUS AGRARIUS PALLAS, 1771) SEASONAL DYNAMICS AND ITS ROLE AS A VECTOR OF IXODID TICKS." In XXVI savetovanje o biotehnologiji sa međunarodnim učešćem. University of Kragujevac, Faculty of Agronomy, 2021. http://dx.doi.org/10.46793/sbt26.291p.
Full textBarr, Kyla N., Craig J. Goergen, Maj Hedehus, Junya Azuma, Charles A. Taylor, Philip S. Tsao, and Joan M. Greve. "Quantification of Abdominal Aortic Aneurysm Disease Progression Using Small Animal Magnetic Resonance Imaging." In ASME 2010 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2010. http://dx.doi.org/10.1115/sbc2010-19009.
Full textNtokou, Aglaia, Marten Szibor, Werner Seeger, Rory Morty, and Katrin Ahlbrecht. "Murine lung lipofibroblast lineage tracing." In ERS International Congress 2016 abstracts. European Respiratory Society, 2016. http://dx.doi.org/10.1183/13993003.congress-2016.pa1815.
Full textBatista, Michael, Hadi T. Nia, Karen Cox, Christine Ortiz, Alan J. Grodzinsky, Dick Heinegård, and Lin Han. "Effects of Chondroadherin on Cartilage Nanostructure and Biomechanics via Murine Model." In ASME 2013 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2013. http://dx.doi.org/10.1115/sbc2013-14516.
Full textReports on the topic "Murids"
Arnsdorf, Jeffrey. New Perspectives on Johannes de Muris and his Notitia artis musicae. Portland State University Library, January 2000. http://dx.doi.org/10.15760/etd.7496.
Full textFreedman, Robert B. Retratos de Mujeres en Bioquímica: Muriel Wheldale. Sociedad Española de Bioquímica y Biología Molecular, July 2012. http://dx.doi.org/10.18567/sebbmdiv_rmb.2012.07.1.
Full textLu, Jinhua. The Role of the MHV Receptor and Related Glycoproteins in Murine Hepatitis Virus Infection of Murine Cell Lines. Fort Belvoir, VA: Defense Technical Information Center, March 1995. http://dx.doi.org/10.21236/ad1011449.
Full textLopez-Diego, Rocio S., and Gregory M. Shackleford. Identification of Oncogenes Cooperating in Murine Mammary Tumorigenesis. Fort Belvoir, VA: Defense Technical Information Center, June 2001. http://dx.doi.org/10.21236/ada396673.
Full textLopez-Diego, Rocio S., and Gregory M. Shackleford. Identification of Oncogenes Cooperating in Murine Mammary Tumorigenesis. Fort Belvoir, VA: Defense Technical Information Center, June 2002. http://dx.doi.org/10.21236/ada409479.
Full textLuhmann. MURI94 Western Consortium on High Energy Microwave Sources. Fort Belvoir, VA: Defense Technical Information Center, May 2000. http://dx.doi.org/10.21236/ada378846.
Full textCook, Alonzo D. Realistic Murine Model for Streptozotocin-induced Diabetic Peripheral Neuropathy. Science Repository OÜ, August 2018. http://dx.doi.org/10.31487/j.rgm.2018.02.006.
Full textBeamer, Wesley G. Genetic and Dynamic Analyses of Murine Peak Bone Density. Fort Belvoir, VA: Defense Technical Information Center, October 2001. http://dx.doi.org/10.21236/ada400443.
Full textBoxer, Robert B., and Lewis A. Chodosh. Role of Murine BRCA1 Protein Interactions in DNA Repair. Fort Belvoir, VA: Defense Technical Information Center, July 2001. http://dx.doi.org/10.21236/ada400472.
Full textRichfield, Eric K. A Murine Model of Genetic and Environmental Neurotoxicant Action. Fort Belvoir, VA: Defense Technical Information Center, September 2001. http://dx.doi.org/10.21236/ada415995.
Full text